The Tumor Ablation Market is rapidly gaining traction as a transformative approach in cancer treatment. Valued at USD 1.82 ...

Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another ...

Chris Donaldson was told he had just a few years to live after cancer in his eyes spread to his liver. But he received a new ...

Baird Medical , a leader in minimally invasive medical technologies, proudly sponsored and participated in the 2024 Guangdong ...

After recently facing her 54th chemo treatment, Lindie Liebenberg shares with us her trials and tribulations in her fight against cancer.

HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic tumors were successfully treated in the company sponsored GANNON trial ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

How would you summarize your study for a lay audience? Immunotherapy has revolutionized the management of cancer, including liver malignancies. However, the benefits are limited by multiple mechanisms ...

Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in ...

Antiarrhythmic drugs (AADs) are often used after ablation for atrial fibrillation (AF); the drugs employed vary, but most common are the drugs that were unsuccessful prior to ablation since it ...